Literature DB >> 27122588

Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins.

Matthew P Bronnimann1, Christine M Calton2, Samantha F Chiquette3, Shuaizhi Li4, Mingfeng Lu4, Janice A Chapman2, Kristin N Bratton5, Angela M Schlegel5, Samuel K Campos6,3,7,2.   

Abstract

UNLABELLED: Despite an abundance of evidence supporting an important role for the cleavage of minor capsid protein L2 by cellular furin, direct cleavage of capsid-associated L2 during human papillomavirus 16 (HPV16) infection remains poorly characterized. The conserved cleavage site, close to the L2 N terminus, confounds observation and quantification of the small cleavage product by SDS-PAGE. To overcome this difficulty, we increased the size shift by fusing a compact protein domain, the Propionibacterium shermanii transcarboxylase domain (PSTCD), to the N terminus of L2. The infectious PSTCD-L2 virus displayed an appreciable L2 size shift during infection of HaCaT keratinocytes. Cleavage under standard cell culture conditions rarely exceeded 35% of total L2. Cleavage levels were enhanced by the addition of exogenous furin, and the absolute levels of infection correlated to the level of L2 cleavage. Cleavage occurred on both the HaCaT cell surface and extracellular matrix (ECM). Contrary to current models, experiments on the involvement of cyclophilins revealed little, if any, role for these cellular enzymes in the modulation of furin cleavage. HPV16 L2 contains two consensus cleavage sites, Arg5 (2RHKR5) and Arg12 (9RTKR12). Mutant PSTCD-L2 viruses demonstrated that although furin can cleave either site, cleavage must occur at Arg12, as cleavage at Arg5 alone is insufficient for successful infection. Mutation of the conserved cysteine residues revealed that the Cys22-Cys28 disulfide bridge is not required for cleavage. The PSTCD-L2 virus or similar N-terminal fusions will be valuable tools to study additional cellular and viral determinants of furin cleavage. IMPORTANCE: Furin cleavage of minor capsid protein L2 during papillomavirus infection has been difficult to directly visualize and quantify, confounding efforts to study this important step of HPV infection. Fusion of a small protein domain to the N terminus greatly facilitates direct visualization of the cleavage product, revealing important characteristics of this critical process. Contrary to the current model, we found that cleavage is largely independent of cyclophilins, suggesting that cyclophilins act either in parallel to or downstream of furin to trigger exposure of a conserved N-terminal L2 epitope (RG-1) during infection. Based on this finding, we strongly caution against using L2 RG-1 epitope exposure as a convenient but indirect proxy of furin cleavage.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27122588      PMCID: PMC4936150          DOI: 10.1128/JVI.00038-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

Review 1.  Sorting out the cellular functions of sorting nexins.

Authors:  Carolyn A Worby; Jack E Dixon
Journal:  Nat Rev Mol Cell Biol       Date:  2002-12       Impact factor: 94.444

2.  Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting.

Authors:  Samuel K Campos; Michael A Barry
Journal:  Virology       Date:  2006-02-28       Impact factor: 3.616

3.  Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection.

Authors:  Rebecca M Richards; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

4.  Kallikrein-8 Proteolytically Processes Human Papillomaviruses in the Extracellular Space To Facilitate Entry into Host Cells.

Authors:  Carla Cerqueira; Pilar Samperio Ventayol; Christian Vogeley; Mario Schelhaas
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

Review 5.  The papillomavirus major capsid protein L1.

Authors:  Christopher B Buck; Patricia M Day; Benes L Trus
Journal:  Virology       Date:  2013-06-22       Impact factor: 3.616

Review 6.  Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases.

Authors:  V M Gordon; S H Leppla
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection.

Authors:  Mayim E Wiens; Jason G Smith
Journal:  J Virol       Date:  2014-12-24       Impact factor: 5.103

8.  Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.

Authors:  Patricia M Day; Carl C Baker; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

9.  Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification.

Authors:  M Brandon Parrott; Kristen E Adams; George T Mercier; Hoyin Mok; Samuel K Campos; Michael A Barry
Journal:  Mol Ther       Date:  2003-10       Impact factor: 11.454

10.  Vesicular trafficking of incoming human papillomavirus 16 to the Golgi apparatus and endoplasmic reticulum requires γ-secretase activity.

Authors:  Wei Zhang; Teymur Kazakov; Andreea Popa; Daniel DiMaio
Journal:  mBio       Date:  2014-09-16       Impact factor: 7.867

View more
  22 in total

Review 1.  Cruising the cellular highways: How human papillomavirus travels from the surface to the nucleus.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G Guion; Martin Sapp
Journal:  Virus Res       Date:  2016-10-29       Impact factor: 3.303

2.  Extracellular Conformational Changes in the Capsid of Human Papillomaviruses Contribute to Asynchronous Uptake into Host Cells.

Authors:  Miriam Becker; Lilo Greune; M Alexander Schmidt; Mario Schelhaas
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

Review 3.  HPV entry into cells.

Authors:  Pinar Aksoy; Elinor Y Gottschalk; Patricio I Meneses
Journal:  Mutat Res Rev Mutat Res       Date:  2016-09-23       Impact factor: 5.657

4.  Human Papillomavirus infection requires the CCT Chaperonin Complex.

Authors:  Marina Bugnon Valdano; Paola Massimi; Justyna Broniarczyk; David Pim; Michael Myers; Daniela Gardiol; Lawrence Banks
Journal:  J Virol       Date:  2021-03-17       Impact factor: 5.103

Review 5.  The long and winding road: human papillomavirus entry and subcellular trafficking.

Authors:  Michelle A Ozbun; Samuel K Campos
Journal:  Curr Opin Virol       Date:  2021-08-17       Impact factor: 7.121

6.  The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.

Authors:  Elena Wüstenhagen; Laura Hampe; Fatima Boukhallouk; Marc A Schneider; Gilles A Spoden; Inka Negwer; Kaloian Koynov; W Martin Kast; Luise Florin
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

7.  The cellular endosomal protein stannin inhibits intracellular trafficking of human papillomavirus during virus entry.

Authors:  Alex Lipovsky; Asu Erden; Eriko Kanaya; Wei Zhang; Mac Crite; Clinton Bradfield; John MacMicking; Daniel DiMaio; John W Schoggins; Akiko Iwasaki
Journal:  J Gen Virol       Date:  2017-10-23       Impact factor: 3.891

Review 8.  Subcellular Trafficking of the Papillomavirus Genome during Initial Infection: The Remarkable Abilities of Minor Capsid Protein L2.

Authors:  Samuel K Campos
Journal:  Viruses       Date:  2017-12-03       Impact factor: 5.048

9.  Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosis.

Authors:  Christine M Calton; Matthew P Bronnimann; Ariana R Manson; Shuaizhi Li; Janice A Chapman; Marcela Suarez-Berumen; Tatum R Williamson; Sudheer K Molugu; Ricardo A Bernal; Samuel K Campos
Journal:  PLoS Pathog       Date:  2017-05-02       Impact factor: 6.823

10.  Antibody Competition Reveals Surface Location of HPV L2 Minor Capsid Protein Residues 17-36.

Authors:  Stephanie M Bywaters; Sarah A Brendle; Kerstin P Tossi; Jennifer Biryukov; Craig Meyers; Neil D Christensen
Journal:  Viruses       Date:  2017-11-10       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.